Opioid-induced second window of cardioprotection: Potential role of mitochondrial K(ATP) channels

Circulation Research

Volumn 84, Issue 7, 1999, Pages 846-851

  Fryer, Ryan M ^a   Hsu, Anna K ^a   Eells, Janis T ^a   Nagase, Hiroshi ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cardioprotection; Mitochondria; Quinolines; Receptors, opioid

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 5 HYDROXYDECANOIC ACID; 7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; GLIBENCLAMIDE; ION CHANNEL; OPIATE AGONIST; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART PROTECTION; INTRAPERITONEAL DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033574686     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.7.846     Document Type: Article

References (34)

1. Schultz J, Rose E, Yao Z, Gross G. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 1995; 268:H2157-H2161.
2. ATP channels. Am J Physiol. 1998;274:H909-H914.
3. Miki T, Cohen M, Downey J. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 1998;186:3-12.
4. Yellon DM, Baxter GA. "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol. 1995;27:1023-1034.
5. Baxter GF, Marber MM, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation. 1994;90:2993-3000.
6. Yamashita N, Hoshida S, Taniguchi N, Kuzuya T, Hori M. A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 1998;30:1181-1189.
7. Baxter GF, Goma FM, Yellon DM. Characterization of the infarctlimiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 1997;92: 159-167.
8. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br J Pharmacol. 1995;115:222-224.
9. Imagawa J, Baxter GF, Yellon DM. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol. 1997;29:1885-1893.
10. Qian Y, Shipley J, Levassuer J, Kukreja R. Dissociation of heat shock proteins expression with ischemic tolerance by whole body hyperthermia in rat heart. J Mol Cell Cardiol. 1998;30:1163-1172.
11. Ventura C, Maioli M, Pintus G, Posadino A, Tadolini B. Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei. J Biol Chem. 1998;273:13383-13386.
12. Gutstein H, Rubie E, Mansour A, Akil H, Woodgett J. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology. 1997;87:1118-1126.
13. Gross G, Auchampach J. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning. Circ Res. 1992;70: 223-233.
14. Schultz J, Yao Z, Cavero I, Gross G. Glibenclamide-induced blockage of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol. 1997;272:H2607-H2615.
15. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 1997;29:1055-1060.
16. Klein H, Puschmann S, Schaper J, Schaper W. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch [Pathol Anat]. 1981;393:287-297.
17. 1-receptor activation in the rabbit. J Cardiovasc Pharmacol. 1997;29:631-638.
18. 1-but not μ-or κ-opioid receptors. Circulation. 1998; 97:1282-1289.
19. + channels. Circ Res. 1996;79:399-406.
20. Bell S, Sack M, Patel A, Opie L, Yellon D. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. Circulation. 1998;98:I-486. Abstract.
21. Baxter G, Goma F, Yellon D. Duration of the "second window of protection" following ischemic preconditioning in the rabbit. J Mol Cell Cardiol. 1995;27:A162. Abstract.
22. Ytrehus K, Liu Y, Downey J. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266: H1145-H1152.
23. Tosaki A, Maulik N, Engelman D, Engelman R, Das D. The role of protein kinase C in ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol. 1996;28:723-731.
24. + channel from rat liver and beef heart mitochondria. J Biol Chem. 1992;267:26062-26069.
25. ATP channel as a receptor for potassium channel openers. J Biol Chem. 1996;271:8796-8799.
26. + channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
27. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81: 1072-1082.
28. Liu Y, Sato T, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
29. + channels by protein kinase C. Circ Res. 1998;83:110-114.
30. ATP channel by glyburide and 5-hydroxydecanoic acid. J Biol Chem. 1998;273:13578-13582.
31. ATP channel activation in a rabbit model of chronic myocardial hypoxia. FASEB J. 1998;12:A999. Abstract.
32. + channels modulate cardiac mitochondrial function. Am J Physiol. 1998;275:H1567-H1576.
33. Halestrap A. Regulation of mitochondrial metabolism through changes in matrix volume. Biochem Soc Trans. 1994;22:522-529.
34. Sun J, Tang X, Park S, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-576.